Important: RNK Health's semaglutide and tirzepatide programs require a prescription from a licensed physician. This article is for informational purposes only and does not constitute medical advice. Compounded medications are not FDA-approved drugs. The decision between medication types should be made in consultation with a qualified healthcare provider. Individual results vary.
One of the most common questions I get from readers looking at RNK Health is a version of this: “Should I start with semaglutide or go straight to tirzepatide?” It's the right question to ask, and the answer isn't the same for everyone. RNK Health offers three formats: injectable semaglutide (from $197/month), oral semaglutide (from $198/month), and injectable tirzepatide (from $297/month). Understanding the actual clinical and practical differences between them — not just the price gap — is what this article is for. I'm also going to be clear about what we do and don't know about the oral format specifically, because it's where most reviews go quiet.
The Mechanism Difference: Why It Matters
Semaglutide works by activating the GLP-1 receptor — a receptor involved in insulin release, appetite signaling, and gastric motility. When you inject or take oral semaglutide, you're amplifying a signal your body already produces naturally after eating, telling your brain you're full and slowing the rate at which your stomach empties. This mechanism works, and the clinical trial data confirms it works well: in the 68-week STEP 1 trial, participants on semaglutide lost an average of 15% of body weight versus 2% on placebo.
Tirzepatide activates two receptors: GLP-1 and GIP (glucose-dependent insulinotropic polypeptide). GIP is another incretin hormone involved in fat metabolism and insulin regulation. The dual mechanism appears to amplify outcomes beyond what GLP-1 activation alone produces. In the 72-week SURMOUNT-1 trial, tirzepatide produced average weight loss of approximately 15% at the 5 mg dose, climbing to approximately 21% at the 15 mg dose, versus 3.1% on placebo. The 2025 SURMOUNT-5 head-to-head trial published in the New England Journal of Medicine directly compared the two at maximum tolerated doses: tirzepatide produced approximately 20% average body weight loss versus approximately 14% for semaglutide. These are meaningful differences at the population level — though individual response always varies.
Injectable Semaglutide: The Established Starting Point
Injectable semaglutide is the format with the deepest clinical evidence, the most standardized dosing protocols, and the longest real-world track record in the compounded telehealth space. Standard dosing starts low (typically 0.25 mg weekly) and titrates upward over months to minimize side effects. The injection is subcutaneous — into a pinch of skin on the abdomen, thigh, or upper arm — and most patients adapt quickly. At $197/month from RNK Health, injectable semaglutide is the most cost-efficient starting point for people who are new to GLP-1 therapy.
Who it makes the most sense for: People who are GLP-1 naive (never tried it before) and want to start with the best-studied format. People who are comfortable with self-injection or willing to learn — the supplies are included in the RNK Health program. People managing cost as a primary constraint. People who want the option of titrating carefully with physician guidance before committing to a higher-cost option.
Oral Semaglutide: Convenience With Important Caveats
RNK Health's oral semaglutide option (from $198/month) is one of the most unusual price points in this space — the one-dollar premium over injectable is striking when oral formats from other providers frequently command significant markups. For people who strongly prefer avoiding injections, it's worth understanding before assuming oral is the obvious choice.
The FDA-approved branded oral semaglutide is Rybelsus, which has a significantly lower bioavailability than injectable semaglutide and very specific dosing requirements: it must be taken first thing in the morning, with no more than 4 ounces of plain water, at least 30 minutes before eating or drinking anything else, and at least 30 minutes before other medications. Missing these requirements significantly reduces absorption. For compounded oral semaglutide specifically — which is what RNK Health offers — I want to be transparent: there is no published clinical data on compounded oral semaglutide equivalent to the injectable trial data. The injectable format has years of real-world telehealth data behind it. Oral compounded semaglutide is newer, and your physician will need to evaluate whether it's appropriate for your situation. That conversation is worth having explicitly before choosing this format.
Who it makes the most sense for: People who are genuinely needle-averse and for whom injections present a meaningful barrier to adherence. People who discuss the oral format explicitly with their physician and understand the bioavailability and dosing protocol differences. People who are willing to be disciplined about morning dosing timing.
Tirzepatide: The Higher-Ceiling Option
At $297/month, tirzepatide is RNK Health's most expensive GLP-1 option — but the $100/month premium over injectable semaglutide reflects a meaningfully different mechanism and a stronger average outcome profile in the trial data. For people who haven't responded adequately to semaglutide, or who are evaluating options and want to start with the format showing the highest average weight loss in clinical trials, tirzepatide is worth considering.
The important caveats: “average” trial outcomes don't predict individual response. Some patients respond better to semaglutide than to tirzepatide. The dual GIP/GLP-1 mechanism also means a somewhat different side effect profile — GIP activation may alter the nausea pattern compared to GLP-1-only agents, though gastrointestinal effects remain the most commonly reported with both. The titration protocol is similar to semaglutide — starting low and increasing gradually is standard practice. At $297/month, the 12-month cost of tirzepatide through RNK Health is still a fraction of branded Zepbound's list price, while accessing the same active ingredient.
Who it makes the most sense for: People who have tried semaglutide without adequate response and are considering escalating. People whose physician recommends tirzepatide based on their clinical profile. People whose primary goal is maximum weight reduction potential and for whom the $100/month premium is manageable. People who want the dual-agonist mechanism from the start and can afford the higher monthly cost.
Head-to-Head Summary
Injectable Semaglutide ($197/month): Best clinical evidence base, established dosing protocols, most cost-efficient, best starting point for most people new to GLP-1 therapy.
Oral Semaglutide ($198/month): Avoids injection, but requires strict dosing discipline and has less real-world compounded data. Discuss explicitly with your physician before choosing.
Tirzepatide ($297/month): Dual mechanism, strongest average trial outcomes, $100/month more. Makes sense for people who want the highest-ceiling option or who haven't responded adequately to semaglutide.
For context on how RNK Health compares to other telehealth providers offering similar medications, see my GLP-1 telehealth comparison for 2026. For a full breakdown of the RNK Health program structure, pricing, and the OpenLoop physician network, see my RNK Health review. If side effects are a concern before you start, my compounded semaglutide side effects guide walks through the evidence and practical management strategies.
Also worth noting: if you're researching other telehealth GLP-1 providers, my review of MEDVi's GLP-1 program is another data point for comparison.
Frequently Asked Questions
What is the difference between semaglutide and tirzepatide? Semaglutide activates one receptor (GLP-1). Tirzepatide activates two (GLP-1 and GIP). Head-to-head trial data published in NEJM 2025 found tirzepatide produced approximately 20% average body weight loss versus approximately 14% for semaglutide at maximum tolerated doses.
Is oral semaglutide as effective as injectable? Injectable semaglutide has more predictable absorption and a longer evidence base. Oral semaglutide has specific food and water timing requirements that significantly affect absorption if not followed. For compounded oral specifically, comparable efficacy data to the injectable format is not currently available. Discuss with your physician.
Why does tirzepatide cost $100 more per month? Tirzepatide is a more complex molecule with a dual mechanism. Compounding cost of the active ingredient is higher than semaglutide.
Can I switch between formats at RNK Health? Any medication change requires physician evaluation. RNK Health's ongoing physician and coaching access means you can raise this with your care team during treatment.